Literature DB >> 15481713

Early surgery-related complications after aneurysm clip placement: an analysis of causes and patient outcomes.

Nancy McLaughlin1, Michel W Bojanowski.   

Abstract

OBJECT: Most reports of series on ruptured intracranial aneurysms contain information on select intraoperative complications. An understanding of all surgical complications, however, may guide us toward improved surgical procedures and enrich discussions concerning alternative management strategies, such as endovascular treatment, which are not exempt from complications and aneurysm recurrence.
METHODS: The study consists of a retrospective review of the charts, images, and notes from follow-up visits of 143 consecutive patients with subarachnoid hemorrhage (SAH) who were surgically treated during a 3-year period by one neurosurgeon. A surgical complication was determined based on findings of a clinical and/or radiological study in the absence of confounding factors such as the initial SAH ictus, vasospasm, hydrocephalus, and septic status. Functional outcome was assessed between 2 and 3 months post-SAH by using the Glasgow Outcome Scale (GOS). A procedure-related surgical complication was diagnosed in 29 (20.3%) of 143 patients studied. A brain tissue injury, including cerebral edema and hemorrhagic contusions, was diagnosed in 6.3% of patients, an unpredicted residual aneurysm neck in 5.3% of patients, and a cranial nerve deficit in 2.8% of patients. Functional outcome was good in 22 (75.9%) of the 29 patients with surgical complications. Death due to a surgical complication occurred in one (0.7%) of 143 patients.
CONCLUSIONS: Surgical complications are more prevalent than previously thought. They may have been overlooked previously because of the high percentage of good functional outcomes and low mortality rates in this group. The identification of surgical complications may encourage the search for solutions to improve surgical treatment of aneurysmal SAH.

Entities:  

Mesh:

Year:  2004        PMID: 15481713     DOI: 10.3171/jns.2004.101.4.0600

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Reversibility of extensive hemispheric cytotoxic cerebral edema following subarachnoid hemorrhage.

Authors:  Nancy McLaughlin; Michel W Bojanowski
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Endovascular management of intracerebral and subarachnoid hemorrhage.

Authors:  Franklin A Marden; Soma Sinha Roy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

3.  Correlation of measured and calculated serum osmolality during mannitol or hypertonic saline infusion in patients after craniotomy: a study protocol and statistical analysis plan for a randomised controlled trial.

Authors:  Qian Li; Ming Xu; Jian-Xin Zhou
Journal:  BMJ Open       Date:  2014-04-23       Impact factor: 2.692

4.  Staged treatment for ruptured wide-neck intracranial aneurysm with intentional partial coiling in the acute phase followed by definitive treatment.

Authors:  Hiroki Yamazaki; Toshiyuki Fujinaka; Tomohiko Ozaki; Tomoki Kidani; Keisuke Nishimoto; Kowashi Taki; Naoki Nishizawa; Keijiro Murakami; Yonehiro Kanemura; Shin Nakajima
Journal:  Surg Neurol Int       Date:  2022-07-22

5.  Delayed Optochiasmal Arachnoiditis following Intervention for a Subarachnoid Haemorrhage.

Authors:  Patrick Yu-Wai-Man; Christopher Neoh
Journal:  Ophthalmol Int       Date:  2013

6.  Adverse intraoperative events during surgical repair of ruptured cerebral aneurysms: a systematic review.

Authors:  William R Muirhead; Patrick J Grover; Ahmed K Toma; Danail Stoyanov; Hani J Marcus; Mary Murphy
Journal:  Neurosurg Rev       Date:  2020-06-16       Impact factor: 3.042

7.  Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double-blinded, randomised controlled trial.

Authors:  Qian Li; Han Chen; Jing-Jing Hao; Ning-Ning Yin; Ming Xu; Jian-Xin Zhou
Journal:  BMC Anesthesiol       Date:  2015-10-07       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.